Xeris Biopharma Holdings Inc (XERS)
3.08
+0.04
(+1.32%)
USD |
NASDAQ |
Nov 22, 14:09
Xeris Biopharma Holdings 1 Year Total Returns (Daily): 74.71% for Nov. 21, 2024
1 Year Total Returns (Daily) Chart
Historical 1 Year Total Returns (Daily) Data
Date | Value |
---|---|
November 21, 2024 | 74.71% |
November 20, 2024 | 68.13% |
November 19, 2024 | 70.06% |
November 18, 2024 | 63.84% |
November 15, 2024 | 98.64% |
November 14, 2024 | 95.51% |
November 13, 2024 | 94.44% |
November 12, 2024 | 86.94% |
November 11, 2024 | 94.66% |
November 08, 2024 | 75.25% |
November 07, 2024 | 79.20% |
November 06, 2024 | 80.54% |
November 05, 2024 | 71.58% |
November 04, 2024 | 69.47% |
November 01, 2024 | 72.73% |
October 31, 2024 | 75.96% |
October 30, 2024 | 93.41% |
October 29, 2024 | 100.6% |
October 28, 2024 | 100.6% |
October 25, 2024 | 84.97% |
October 24, 2024 | 76.09% |
October 23, 2024 | 84.02% |
October 22, 2024 | 73.56% |
October 21, 2024 | 74.14% |
October 18, 2024 | 72.88% |
Date | Value |
---|---|
October 17, 2024 | 63.44% |
October 16, 2024 | 60.00% |
October 15, 2024 | 91.14% |
October 14, 2024 | 87.97% |
October 11, 2024 | 76.36% |
October 10, 2024 | 62.57% |
October 09, 2024 | 66.27% |
October 08, 2024 | 68.00% |
October 07, 2024 | 67.43% |
October 04, 2024 | 77.38% |
October 03, 2024 | 81.71% |
October 02, 2024 | 66.29% |
October 01, 2024 | 50.00% |
September 30, 2024 | 53.23% |
September 27, 2024 | 51.05% |
September 26, 2024 | 55.49% |
September 25, 2024 | 52.17% |
September 24, 2024 | 56.67% |
September 23, 2024 | 53.33% |
September 20, 2024 | 54.21% |
September 19, 2024 | 51.02% |
September 18, 2024 | 45.73% |
September 17, 2024 | 45.00% |
September 16, 2024 | 44.00% |
September 13, 2024 | 38.46% |
Total Return Definition
The Total return is the change in price over a specific period of time that includes dividends and distributions paid.
1 Year Total Returns (Daily) Range, Past 5 Years
-85.58%
Minimum
Mar 18 2020
200.0%
Maximum
Mar 16 2021
-11.38%
Average
-32.73%
Median
1 Year Total Returns (Daily) Benchmarks
Zevra Therapeutics Inc | 102.4% |
NovaBay Pharmaceuticals Inc | -93.43% |
Palatin Technologies Inc | -53.31% |
iBio Inc | -54.05% |
Theriva Biologics Inc | -88.85% |